The 103rd Annual Meeting of The Physiological Society of Japan
Advanced Search

Session Details

SymposiumAcademic and Research Committee Symposium

[1S01m]【J】Utilization and application of "digital biomarker": status quo and prospects

Tue. Mar 10, 2026 8:50 AM - 10:40 AM JST
Tue. Mar 10, 2026 11:50 PM - 1:40 AM UTC
Room 1(Main Academic Building, 3F, Hall 1)
Organizers/Chairs: Hiroshi Hibino (The University of Osaka), Chie Emoto (Chugai Pharmaceutical Co., Ltd.)
Recently, wearable devices such as smartwatches have allowed us to monitor and record a variety of activities and signals in humans over time. By analyzing such quantitative and objective measurements called "digital biomarkers," there is a growing trend to not only visualize health conditions in daily life and the effects of various interventions on disease treatment, but also to realize early diagnosis and prediction of diseases. In this background, different industries including pharmaceutical companies intend to utilize digital biomarkers in order to advance medical care and healthcare. Nevertheless, relevance of these parameters to physiological and pathological significance have not yet been fully understood; this standpoint requires physiologists to play essential roles. The symposium invites leading experts from industry, government, and academia who are actively working on digital biomarkers to share the current status of their utilization and discuss the prospects.
8:50 AM - 8:52 AM JST(11:50 PM - 11:52 PM UTC)

Introduction

8:52 AM - 9:07 AM JST(11:52 PM - 12:07 AM UTC)

[1S01m-01]Advances in Health Monitoring and Predictive Medicine Using Digital Biomarkers and AI

*Eiryo Kawakami1,2,3 (1. RIKEN, 2. Chiba University, 3. The University of Osaka)
Comment()
9:07 AM - 9:11 AM JST(12:07 AM - 12:11 AM UTC)

Q&A

9:11 AM - 9:26 AM JST(12:11 AM - 12:26 AM UTC)

[1S01m-02]Clinical Application of Respiratory Stability Time for Early Detection of Worsening Heart Failure Using a Non-Contact Tele-Monitoring System

*Shigeru Miyagawa1, Eiji Asanoi2 (1. Department of Cardiovascular Surgery, The University of Osaka, 2. Toyama West General Hospital)
Comment()
9:26 AM - 9:30 AM JST(12:26 AM - 12:30 AM UTC)

Q&A

9:30 AM - 9:45 AM JST(12:30 AM - 12:45 AM UTC)

[1S01m-03]Utilizing digital biomarkers developed from continuous unstructured data and AI medical

*Kazumichi Minato1 (1. TechDoctor, inc.)
Comment()
9:45 AM - 9:49 AM JST(12:45 AM - 12:49 AM UTC)

Q&A

9:49 AM - 10:04 AM JST(12:49 AM - 1:04 AM UTC)

[1S01m-04]Utilization of Digital Biomarkers in Drug Development

*Norihiro Kawabata1 (1. Chugai Pharmaceutical Co., Ltd.)
Comment()
10:04 AM - 10:08 AM JST(1:04 AM - 1:08 AM UTC)

Q&A

10:08 AM - 10:23 AM JST(1:08 AM - 1:23 AM UTC)

[1S01m-05]Digital biomarkers and approval review of medical devices

*Kensuke Ishii1 (1. Pharmaceuticals and Medical Devices Agency)
Comment()
10:23 AM - 10:27 AM JST(1:23 AM - 1:27 AM UTC)

Q&A

10:27 AM - 10:38 AM JST(1:27 AM - 1:38 AM UTC)

Discussion

10:38 AM - 10:40 AM JST(1:38 AM - 1:40 AM UTC)

Conclusion

Back to Category List